Literature DB >> 6110459

Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.

G M Besser, G Delitala, A Grossman, W A Stubbs, T Yeo.   

Abstract

1. The effects of chlorpromazine, haloperidol, metoclopramide and domperidone on the release of prolactin from perfused columns of dispersed rat anterior pituitary cells were studied. 2. Chlorpromazine, haloperidol, metoclopramide and domperidone antagonized the dopamine-mediated inhibition of prolactin release at low concentrations. 3. Each dopamine antagonist displaced the dose-response curve for dopamine-induced suppression of prolactin release to the right in a parallel manner. 4. At higher concentrations, the four drugs became less effective as dopamine antagonists. 5. At high concentrations in the absence of dopamine, chlorpromazine, haloperidol, metoclopramide and domperidone paradoxically suppressed prolactin secretion by an unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6110459      PMCID: PMC2044467          DOI: 10.1111/j.1476-5381.1980.tb10974.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

2.  Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.

Authors:  M G Caron; M Beaulieu; V Raymond; B Gagné; J Drouin; R J Lefkowitz; F Labrie
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

3.  Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion.

Authors:  R M MacLeod; J E Lehmeyer
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

4.  Letter: Metaclopramide and prolactin.

Authors:  A S McNeilly; M O Thorner; G Volans; G M Besser
Journal:  Br Med J       Date:  1974-06-29

5.  Inhibition of rat prolactin release by apomorphine in vivo and in vitro.

Authors:  E B Smalstig; B D Sawyer; J A Clemens
Journal:  Endocrinology       Date:  1974-07       Impact factor: 4.736

6.  Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel.

Authors:  J Takahara; A Arimura; A V Schally
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

7.  Further evidence for the existence of tubero-infundibular dopamine neurons.

Authors:  K Fuxe; T Hökfelt
Journal:  Acta Physiol Scand       Date:  1966 Jan-Feb

8.  Binding of dopamine to bovine anterior pituitary gland membranes.

Authors:  M A Calabro; R M MacLeod
Journal:  Neuroendocrinology       Date:  1978       Impact factor: 4.914

9.  Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

Authors:  D L Kleinberg; G L Noel; A G Frantz
Journal:  N Engl J Med       Date:  1977-03-17       Impact factor: 91.245

10.  Dopamine in hypophysial portal plasma of the rat during the estrous cycle and throughout pregnancy.

Authors:  N Ben-Jonathan; C Oliver; H J Weiner; R S Mical; J C Porter
Journal:  Endocrinology       Date:  1977-02       Impact factor: 4.736

View more
  5 in total

Review 1.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

2.  Specific in vivo binding of 3H-spiperone to individual lobes of the pituitary gland of the rat. Evidence for the labelling of dopamine receptors.

Authors:  C Köhler; K Fahlberg
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  In vivo labelling of pituitary dopamine D-2 receptors in the male rat using [3H]-raclopride.

Authors:  C Köhler; G Karlsson-Boethius
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

Review 4.  Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

5.  Octopamine signaling in the metazoan pathogen Schistosoma mansoni: localization, small-molecule screening and opportunities for drug development.

Authors:  Nelly El-Sakkary; Steven Chen; Michelle R Arkin; Conor R Caffrey; Paula Ribeiro
Journal:  Dis Model Mech       Date:  2018-07-30       Impact factor: 5.758

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.